Status:
COMPLETED
Understanding the Sleep Apnea/Insomnia Interaction
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Sleep Apnea Syndromes
Sleep Initiation and Maintenance Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Nearly half of all patients with obstructive sleep apnea have insomnia symptoms, and in some, but not all cases, these insomnia symptoms are caused by the obstructive sleep apnea. The purpose of this ...
Eligibility Criteria
Inclusion
- Sleep Apnea
- Insomnia
- Age \>18
Exclusion
- Sedative/psychoactive drug use recently
- Other clinically significant sleep disorders
- Previous treatment for obstructive sleep apnea (OSA)
- Requires oxygen or bilevel PAP therapy
- Clinically unstable medical condition
- Recent shift work
- Significant alcohol use
- Other clinically significant causes of insomnia
- Illicit drug use
- Prescription stimulants
- Safety restrictions
- Unable to treat sleep apnea with positive airway pressure therapy
- Communication barriers
- Cognitive impairment
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01824472
Start Date
March 1 2013
End Date
March 1 2017
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania Health System
Philadelphia, Pennsylvania, United States, 19104